Search research articles
Contact Us
Filters
Showing results (91-100 of 111) with videos related to
Page
of 12
Sort By:
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
June 28, 2021
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies
Sixten Körper, Bernd Jahrsdörfer, Victor M Corman, et al.
Haematologica
|
October 15, 2020
Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations
Johanna Flach, Johann-Christoph Jann, Antje Knaflic, et al.
Frontiers in Immunology
|
April 6, 2019
Shaping of CD56<sup>bri</sup> Natural Killer Cells in Patients With Steroid-Refractory/Resistant Acute Graft-vs.-Host Disease via Extracorporeal Photopheresis
Ming Ni, Lei Wang, Mingya Yang, et al.
Cytotherapy
|
May 27, 2014
Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications
Patrick Wuchter, Karen Bieback, Hubert Schrezenmeier, et al.
Theranostics
|
May 23, 2017
Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responses
Michael Schmitt, Anita Schmitt, Markus Wiesneth, et al.
Clinical Genitourinary Cancer
|
July 23, 2016
Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012
Andrea Necchi, Salvatore Lo Vullo, Marco Bregni, et al.
Frontiers in Immunology
|
October 24, 2018
Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects
Lei Wang, Ming Ni, Angela Hückelhoven-Krauss, et al.
British Journal of Haematology
|
January 24, 2021
High erythroferrone expression in CD71<sup>+</sup> erythroid progenitors predicts superior survival in myelodysplastic syndromes
Vladimir Riabov, Maximilian Mossner, Alexandra Stöhr, et al.
European Journal of Haematology
|
April 4, 2017
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsE
Marc-Andrea Baertsch, Jana Schlenzka, Katharina Lisenko, et al.
Leukemia
|
September 11, 2020
Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML
Rüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 111) with videos related to
Sort By:
Page
of 12
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
June 28, 2021
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies
Sixten Körper, Bernd Jahrsdörfer, Victor M Corman, et al.
Haematologica
|
October 15, 2020
Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations
Johanna Flach, Johann-Christoph Jann, Antje Knaflic, et al.
Frontiers in Immunology
|
April 6, 2019
Shaping of CD56<sup>bri</sup> Natural Killer Cells in Patients With Steroid-Refractory/Resistant Acute Graft-vs.-Host Disease via Extracorporeal Photopheresis
Ming Ni, Lei Wang, Mingya Yang, et al.
Cytotherapy
|
May 27, 2014
Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications
Patrick Wuchter, Karen Bieback, Hubert Schrezenmeier, et al.
Theranostics
|
May 23, 2017
Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responses
Michael Schmitt, Anita Schmitt, Markus Wiesneth, et al.
Clinical Genitourinary Cancer
|
July 23, 2016
Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012
Andrea Necchi, Salvatore Lo Vullo, Marco Bregni, et al.
Frontiers in Immunology
|
October 24, 2018
Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects
Lei Wang, Ming Ni, Angela Hückelhoven-Krauss, et al.
British Journal of Haematology
|
January 24, 2021
High erythroferrone expression in CD71<sup>+</sup> erythroid progenitors predicts superior survival in myelodysplastic syndromes
Vladimir Riabov, Maximilian Mossner, Alexandra Stöhr, et al.
European Journal of Haematology
|
April 4, 2017
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsE
Marc-Andrea Baertsch, Jana Schlenzka, Katharina Lisenko, et al.
Leukemia
|
September 11, 2020
Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML
Rüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker, et al.
Page
of 12